Juncture Wealth Strategies LLC Buys Shares of 18,277 Ultralife Co. (NASDAQ:ULBI)

Juncture Wealth Strategies LLC bought a new stake in Ultralife Co. (NASDAQ:ULBI) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 18,277 shares of the technology company’s stock, valued at approximately $165,000. Juncture Wealth Strategies LLC owned about 0.11% of Ultralife at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of ULBI. Janney Montgomery Scott LLC boosted its holdings in Ultralife by 10.0% in the 1st quarter. Janney Montgomery Scott LLC now owns 439,100 shares of the technology company’s stock valued at $3,868,000 after purchasing an additional 40,000 shares during the last quarter. Empowered Funds LLC lifted its holdings in shares of Ultralife by 7.8% in the 1st quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock worth $277,000 after acquiring an additional 2,275 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Ultralife by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock worth $4,545,000 after acquiring an additional 6,640 shares during the last quarter. Hillsdale Investment Management Inc. acquired a new position in shares of Ultralife in the 1st quarter worth approximately $166,000. Finally, O Shaughnessy Asset Management LLC acquired a new position in shares of Ultralife in the 1st quarter worth approximately $100,000. 30.68% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ULBI has been the topic of several recent analyst reports. StockNews.com lowered shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd. Benchmark upped their price objective on shares of Ultralife from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, June 27th.

Ultralife Price Performance

Ultralife stock opened at $9.16 on Friday. The firm has a market cap of $152.26 million, a PE ratio of 14.31 and a beta of 0.97. Ultralife Co. has a 52-week low of $6.36 and a 52-week high of $13.39. The company has a quick ratio of 2.06, a current ratio of 4.07 and a debt-to-equity ratio of 0.07. The company’s 50 day moving average is $9.80 and its two-hundred day moving average is $10.37.

Ultralife (NASDAQ:ULBI) last released its earnings results on Thursday, July 25th. The technology company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08. The company had revenue of $42.98 million for the quarter. Ultralife had a net margin of 5.96% and a return on equity of 9.32%.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.